Loading institutional data...
Loading institutional data...
Held by 1,821 of 5,944 reporting institutions (100th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Solve the discounted cash flow backwards, then stress-test the assumptions.
To be worth $62.04 today, the market must believe free cash flow compounds 10.2%/yr for a decade (off $3.5B normalized FCF).
The market's 10.2% is more optimistic than its 9-yr track record.
2-stage DCF · 1.29B shares · net debt $2.7B
mean 10.4% · volatility σ 28% · implied rate exceeded in 2/9 yrs
Central path = implied 10.2%/yr growth; shaded band = ±1σ (28%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Needs granular two-year detail (receivables, PP&E, D&A, SG&A) — not fully reported.
Earnings are backed by cash (FCF ≥ net income) — high quality. Lower/negative accruals = higher quality (Sloan).
Comfortably covers interest; leverage rising year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
The dividend takes 77% of free cash flow — sustainable but with limited headroom. Last year: $2.5B dividends + $2.4B buybacks = $4.9B returned on $3.2B FCF.
9 consecutive years of dividend increases · 12%/yr.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A cash-return story — far more went to shareholders than back into the business (mature, low-reinvestment).
Modest payoff on reinvested capital. Current ROIC on all capital: 9%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
$1.6B of principal comes due within a year. Scheduled principal only (excludes interest & revolver draws). As of 2019-12-31 (10-K).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Coverage is adequate but not comfortable. Effective rate ~22.3% on $2.7B of debt.
Cash vs short-term debt unavailable.
Mostly short-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
EOD close · as of 2026-09-17
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $38.54B 100.0% | $36.44B 100.0% | $36.02B 100.0% | $31.50B 100.0% | $28.72B 100.0% | $26.58B 100.0% | $25.87B 100.0% | $25.94B 100.0% | $25.90B 100.0% | $25.92B 100.0% |
| Cost of Revenue | $27.60B 71.6% | $22.18B 60.9% | $22.25B 61.8% | $20.18B 64.1% | $17.47B 60.8% | $16.14B 60.7% | $15.53B 60.0% | $15.59B 60.1% | $15.86B 61.3% | $15.82B 61.0% |
| Cost of Products | — | — | — | — | — | — | — | — | $15.83B 61.1% | $15.79B 60.9% |
| Gross Profit | $10.94B 28.4% | $14.26B 39.1% | $13.76B 38.2% | $11.31B 35.9% | $11.25B 39.2% | $10.45B 39.3% | $10.34B 40.0% | $10.35B 39.9% | $10.03B 38.7% | $10.10B 39.0% |
| Research & Development | $400.0M 1.0% | $400.0M 1.1% | $380.0M 1.1% | $346.0M 1.1% | $347.0M 1.2% | $332.0M 1.2% | $351.0M 1.4% | $362.0M 1.4% | $366.0M 1.4% | $376.0M 1.5% |
| Selling, General & Admin | $7.17B 18.6% | $7.44B 20.4% | $8.00B 22.2% | $7.38B 23.4% | $6.26B 21.8% | $6.10B 22.9% | $6.14B 23.7% | $6.47B 25.0% | $5.94B 22.9% | $6.55B 25.3% |
| Operating Income | $3.55B 9.2% | $6.34B 17.4% | $5.50B 15.3% | $3.53B 11.2% | $4.65B 16.2% | $3.85B 14.5% | $3.84B 14.9% | $3.31B 12.8% | $3.46B 13.4% | $2.55B 9.9% |
| Interest Expense | $599.0M 1.6% | $508.0M 1.4% | $550.0M 1.5% | $428.0M 1.4% | $365.0M 1.3% | $423.0M 1.6% | $484.0M 1.9% | $462.0M 1.8% | $396.0M 1.5% | $515.0M 2.0% |
| Other Income (Expense), net | -$282.0M -0.7% | -$180.0M -0.5% | -$310.0M -0.9% | -$423.0M -1.3% | -$447.0M -1.6% | -$608.0M -2.3% | -$456.0M -1.8% | -$520.0M -2.0% | -$382.0M -1.5% | -$1.11B -4.3% |
| Pretax Income | $3.01B 7.8% | $6.26B 17.2% | $5.88B 16.3% | $3.23B 10.2% | $4.37B 15.2% | $3.38B 12.7% | $3.45B 13.3% | $2.84B 11.0% | $3.12B 12.1% | $1.45B 5.6% |
| Income Tax Expense | $782.0M 2.0% | $1.47B 4.0% | $1.54B 4.3% | $865.0M 2.7% | $1.19B 4.1% | $1.22B 4.6% | $2.0M 0.0% | $773.0M 3.0% | $666.0M 2.6% | $114.0M 0.4% |
| Net Income | $2.45B 6.4% | $4.61B 12.7% | $4.96B 13.8% | $2.72B 8.6% | $4.30B 15.0% | $3.56B 13.4% | $3.93B 15.2% | $3.32B 12.8% | $2.83B 10.9% | $1.64B 6.3% |
| Per Share | ||||||||||
| EPS (Basic) | $1.89 | $3.44 | $3.64 | $1.97 | $3.06 | $2.48 | $2.72 | $2.25 | $1.87 | $1.05 |
| EPS (Diluted) | $1.89 | $3.42 | $3.62 | $1.96 | $3.04 | $2.47 | $2.69 | $2.23 | $1.85 | $1.04 |
| Weighted Avg Shares (Basic) | 1.29B | 1.34B | 1.36B | 1.38B | 1.40B | 1.43B | 1.45B | 1.47B | 1.51B | 1.56B |
| Weighted Avg Shares (Diluted) | 1.30B | 1.35B | 1.37B | 1.39B | 1.41B | 1.44B | 1.46B | 1.49B | 1.53B | 1.57B |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
EOD close · as of 2026-09-17
Where each multiple sits in its own 14-yr range · 79th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Profit and sales moved in opposite directions this year.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 60.1 | 60.0 | 60.7 | 60.8 | 64.1 | 61.8 | 60.9 | 71.6 |
| Gross Profit | 39.9 | 40.0 | 39.3 | 39.2 | 35.9 | 38.2 | 39.1 | 28.4 |
| R&D | 1.4 | 1.4 | 1.2 | 1.2 | 1.1 | 1.1 | 1.1 | 1.0 |
| SG&A | 25.0 | 23.7 | 22.9 | 21.8 | 23.4 | 22.2 | 20.4 | 18.6 |
| Operating Income | 12.8 | 14.9 | 14.5 | 16.2 | 11.2 | 15.3 | 17.4 | 9.2 |
| Income Tax | 3.0 | 0.0 | 4.6 | 4.1 | 2.7 | 4.3 | 4.0 | 2.0 |
| Net Income | 12.8 | 15.2 | 13.4 | 15.0 | 8.6 | 13.8 | 12.7 | 6.4 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on MDLZ: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Ranked against 229 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| WMT | $852.5B | 39.1× | — | 1.2× | 4.7% | 24.9% | 3.1% | 22.0% | 15.5% | — | 4,273 |
| COST | $396.2B | 49.1× | 30.3× | 1.4× | 8.2% | 12.8% | 2.9% | 27.8% | 23.2% | 0.5× | 4,050 |
| KO | $378.9B | 29.0× | 24.9× | 7.9× | 1.9% | 61.6% | 27.3% | 40.7% | 40.7% | — | 3,427 |
| PG | $346.8B | 22.7× | 16.4× | 4.1× | 0.3% | 51.2% | 19.0% | 30.6% | 18.4% | 1.5× | 3,849 |
| PM | $296.4B | 26.2× | 17.3× | 7.3× | 7.3% | 67.1% | 27.9% | -114% | -115% | 0.0× | 2,744 |
| PEP | $183.0B | 22.3× | 14.9× | 1.9× | 2.3% | 54.1% | 8.8% | 40.4% | 11.8% | 3.3× | 3,404 |
| MO | $116.7B | 16.9× | 13.6× | 5.0× | -3.1% | 62.5% | 29.8% | -198% | 31.3% | 2.5× | 2,375 |
| MDLZ | $80.3B | 32.8× | 18.9× | 2.1× | 5.8% | 28.4% | 6.4% | 9.5% | 8.6% | 0.6× | 1,821 |
| TGT | $72.4B | 19.7× | 10.5× | 0.7× | -1.7% | 27.9% | 3.5% | 22.9% | 12.1% | 1.7× | 1,771 |
| CL | $70.3B | 33.4× | 19.6× | 3.5× | 1.4% | 60.1% | 10.5% | 3948% | 26.5% | 2.0× | 1,873 |
| MNST | $43.5B | — | 16.4× | 5.3× | 10.7% | 55.8% | 23.0% | 23.1% | 23.1% | — | 1,169 |
| KDP | $42.7B | 20.5× | 14.3× | 2.6× | 8.2% | 54.2% | 12.5% | 8.1% | 5.0% | 4.0× | 784 |
| ADM | $42.6B | 39.5× | — | 0.5× | -6.2% | 6.3% | 1.3% | 4.7% | 3.6% | — | 1,070 |
| FMX | $41.0B | — | — | — | — | — | — | — | — | — | 290 |
| JBS | $39.7B | — | — | — | — | — | — | — | — | — | 241 |
| KR | $39.6B | 39.5× | 10.0× | 0.3× | 0.4% | — | 0.7% | 17.1% | 4.7% | 3.0× | 1,327 |
| SYY | $38.6B | 21.2× | 9.7× | 0.5× | 3.2% | 18.4% | 2.2% | 99.9% | 99.9% | — | 1,489 |
| KVUE | $34.2B | 23.5× | 11.7× | 2.3× | -2.1% | 58.1% | 9.7% | 13.7% | 12.0% | 0.5× | 967 |
| HSY | $34.1B | — | 20.1× | 2.9× | 4.4% | 33.5% | 7.6% | 19.0% | 9.3% | 2.5× | 1,406 |
| EL | $33.8B | — | 768.2× | 2.4× | -8.2% | 74.0% | -7.9% | -29.3% | -29.3% | 0.1× | 800 |
| KMB | $32.6B | 16.2× | 10.3× | 2.0× | -2.1% | 36.0% | 12.3% | 135% | 92.0% | 0.2× | 1,585 |
| KHC | $29.3B | — | — | 1.2× | -3.5% | 33.3% | -23.4% | -14.0% | -14.0% | — | 1,059 |
| DG | $27.5B | 18.2× | 8.1× | 0.6× | 5.2% | 30.7% | 3.5% | 17.8% | 17.8% | — | 1,099 |
| KOF | $23.6B | — | — | — | — | — | — | — | — | — | 249 |
| CHD | $23.1B | 31.5× | 18.8× | 3.7× | 1.6% | 44.7% | 11.9% | 18.4% | 11.9% | 1.7× | 1,004 |
Peers = companies sharing MDLZ's sector (Consumer Defensive) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.